Coronavirus inida News
Bharat Biotech's coronavirus vaccine in collaboration with the ICMR has been cleared for the phase 3 of clinical trials.
On October 2, the Hyderabad-based vaccine maker had applied to the DCGI seeking permission to conduct Phase 3 trials.
The firm said that the study would cover around 28,500 subjects in 19 sites, across 10 states.
Loading...